Nitric oxide function in atherosclerosis

作者: K. E. Matthys , H. Bult

DOI: 10.1080/09629359791875

关键词:

摘要: Atherosclerosis is a chronic inflammatory process in the intima of conduit arteries, which disturbs endothelium-dependent regulation vascular tone by labile liposoluble radical nitric oxide (NO) formed constitutive endothelial synthase (eNOS). This defect predisposes to coronary vasospasm and cardiac ischaemia, with anginal pain as typical clinical manifestation. It now appreciated that dysfunction an early event atherogenesis it may also involve microcirculation, atherosclerotic lesions do not develop. On other hand, environment plaques result expression inducible NO (iNOS) isozyme. Whether production causal to, or of, lesion formation still highly debated. Most evidence supports hypothesis release protects against e.g. preventing smooth muscle cell proliferation leukocyte adhesion. Nitric generated isozyme be beneficial replacing failing but excessive damage wall cells, especially combination reactive oxygen intermediates.

参考文章(284)
Hiromichi SUZUKI, Hideki IKENAGA, Keiichi HISHIKAWA, Toshio NAKAKI, Ryuichi KATO, Takao SARUTA, Increases in NO2-/NO3- excretion in the urine as an indicator of the release of endothelium-derived relaxing factor during elevation of blood pressure Clinical Science. ,vol. 82, pp. 631- 634 ,(1992) , 10.1042/CS0820631
K Shimokata, T Kawabe, I Nakashima, K I Isobe, Y Hasegawa, Immunosuppressive activity induced by nitric oxide in culture supernatant of activated rat alveolar macrophages. Immunology. ,vol. 76, pp. 72- 78 ,(1992)
John S. Schroeder, James L. Bolen, Robert A. Quint, David A. Clark, William G. Hayden, Charles B. Higgins, Lewis Wexler, Provocation of coronary spasm with ergonovine maleate: New test with results in 57 patients undergoing coronary arteriography☆ American Journal of Cardiology. ,vol. 40, pp. 487- 491 ,(1977) , 10.1016/0002-9149(77)90060-1
S. M. Bode-Böger, R. H. Böger, A. Creutzig, D. Tsikas, F.-M. Gutzki, K. Alexander, J. C. Frölich, L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clinical Science. ,vol. 87, pp. 303- 310 ,(1994) , 10.1042/CS0870303
T. Scott-Burden, P. M. Vanhoutte, The endothelium as a regulator of vascular smooth muscle proliferation Monograph - American Heart Association. ,vol. 87, ,(1993)
J. Gaboury, R. C. Woodman, D. N. Granger, P. Reinhardt, P. Kubes, Nitric oxide prevents leukocyte adherence: role of superoxide American Journal of Physiology-heart and Circulatory Physiology. ,vol. 265, ,(1993) , 10.1152/AJPHEART.1993.265.3.H862
E N Standfield, L D Buttery, J M Polak, T J Evans, M H Yacoub, D V Parums, D R Springall, A H Chester, Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite Laboratory Investigation. ,vol. 75, pp. 77- 85 ,(1996)
Collins T, Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Laboratory Investigation. ,vol. 68, pp. 499- 508 ,(1993)
Timothy D. Warner, Jane A. Mitchell, Hong Sheng, Ferid Murad, Effects of cyclic GMP on smooth muscle relaxation. Advances in pharmacology (San Diego). ,vol. 26, pp. 171- 194 ,(1994) , 10.1016/S1054-3589(08)60054-X